Blue Genes
About Blue Genes
Blue Genes is a healthcare AI company focused on transforming medication decisions through real-time pharmacogenetics. Their AI-powered platform aims to proactively prevent harmful prescriptions and adverse drug reactions by providing immediate, data-driven recommendations to healthcare providers. The company’s mission is to eliminate genetically driven adverse drug reactions, protect patients, reduce preventable costs for health plans, and bring precision to every prescription decision.
The platform integrates complex genetic insights into clear, actionable guidance at the point of care, helping providers understand how a patient’s unique DNA impacts their response to medications. Blue Genes offers an app-based tool that considers both drug-drug and gene-drug interactions to suggest optimal medications. They also leverage Google’s Gemini AI and Google Cloud to streamline communication with patients and providers through intelligent voice and chat agents, offering HIPAA-aware support and real-time suggestions for alternative therapies when prescriptions are denied.
Blue Genes’ solutions are designed for system compatibility, integrating with Pharmacy Benefit Managers (PBMs), Electronic Medical Records (EMRs), and pharmacy systems. This integration allows for real-time claim denials if a prescribed medication is not efficacious for a patient based on their genetics, without requiring behavioral changes from patients or adding significant administrative burden to providers. They also offer a personalized, at-home genetic testing kit.
Focus Areas
Business Intelligence
| Key Investors | unknown |
| Partnerships | RxSense, Levrx Technology, Level Care, Blackhawk Claims Service |
| Acquisitions | unknown |
| Technology | AI-powered platform, Google's Gemini AI, Google Cloud, patent-pending technology, API for PBM and EMR integration, cloud-native |
| FDA Clearances | unknown cleared products (estimated) |
What Physicians Need to Know
For physicians, Blue Genes offers a powerful tool to move beyond trial-and-error prescribing by providing real-time, personalized medication guidance based on a patient's genetic profile. The platform integrates seamlessly into existing EMRs and PBMs, delivering actionable insights at the point of care without requiring significant changes to clinical workflows. AI-powered clinical support and communication tools reduce administrative burden, offer immediate suggestions for alternative therapies, and help ensure compliance, allowing physicians to focus on delivering exceptional patient care. The goal is to empower providers to prescribe with confidence, reduce adverse drug reactions, and improve patient outcomes by aligning medications with individual genetic profiles.
Blue Genes' platform is designed for seamless integration with leading Pharmacy Benefit Managers (PBMs) and Electronic Medical Records (EMRs). They utilize an open-source API that can be integrated into adjudication engines for real-time claim processing and medication guidance. The company has active partnerships with various PBMs and healthcare technology companies like Levrx and RxSense to embed precision medicine into existing benefit infrastructures.
Reviews & Opinions
Videos
News, demos, and interviews about Blue Genes.
Videos load interactively. If none appear, search YouTube for Blue Genes →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]